Drug:
Reaction: NASOPHARYNGITIS
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26477123 |
US |
49 | 2 |
Fatigue, Nasopharyngitis, Sinusitis, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 502 | 26477179 |
US |
||
Death, Nasopharyngitis, |
||||
TREPROSTINIL, TREPROSTINIL, METOPROLOL TARTRATE, PREDNISOLONE ACETATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FLUOXETINE HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, FUROSEMIDE, ROSUVASTATIN CALCIUM, GABAPENTIN, FINASTERIDE, ERGOCALCIFEROL, IRON, OXYGEN, 0XYGEN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALPRAZOLAM, |
||||
| 503 | 26477228 |
CA |
21 | |
Acne, Anal fissure, Condition aggravated, Cough, Eye pruritus, Fistula, Ocular hyperaemia, Rhinorrhoea, Headache, Nasopharyngitis, Pain, Pilonidal disease, Intentional product use issue, Off label use, Off label use, Intentional product use issue, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
| 504 | 26477354 |
EU |
1 | |
Polyneuropathy, Renal impairment, Epistaxis, Nasopharyngitis, Diarrhoea, Fatigue, Myalgia, Arthralgia, Nausea, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, |
||||
| 505 | 26477485 |
US |
89 | 1 |
Diarrhoea, Alopecia, Nasopharyngitis, Diarrhoea, Sinus congestion, |
||||
TAZEMETOSTAT, LOSARTAN POTASSIUM, LOSARTAN, SIMVASTATIN, ERGOCALCIFEROL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 506 | 26477804 |
US |
75 | 2 |
Nasopharyngitis, Nasopharyngitis, |
||||
RISANKIZUMAB-RZAA, |
||||
| 507 | 26478141 |
US |
73 | 2 |
Nasopharyngitis, Sputum discoloured, |
||||
AVAPRITINIB, ALBUTEROL SULFATE, DIPHENHYDRAMINE HYDROCHLORIDE, BENZTROPINE MESYLATE, BENZTROPINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CROMOLYN SODIUM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, EPINEPHRINE, ADRENALINUM, FAMOTIDINE, GABAPENTIN, HYDROXYZINE PAMOATE, LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MAGNESIUM, METHYLPREDNISOLONE, MELOXICAM, METHOCARBAMOL, METHOCARBAMOL TABLETS, MONTELUKAST SODIUM, MONTELUKAST, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, SELENIUM SULFIDE, SENNOSIDES, SENNA LEAF, SENNA, VITAMIN C, LOTILANER OPHTHALMIC SOLUTION, ZINC GLUCONATE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, |
||||
| 508 | 26478632 |
US |
2 | |
Nasopharyngitis, Nausea, Dysgeusia, Hypothyroidism, |
||||
LEVOTHYROXINE SODIUM, |
||||
| 509 | 26478656 |
GB |
42 | 1 |
Infection susceptibility increased, Immunosuppression, Nasopharyngitis, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 510 | 26478707 |
GB |
72 | 2 |
Lymphadenopathy, Brain fog, Rash vesicular, Dyspnoea, Fatigue, Nasopharyngitis, Myalgia, Rhinorrhoea, |
||||
DENOSUMAB, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 511 | 26478933 |
CA |
43 | 2 |
Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Maternal exposure during pregnancy, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Nasopharyngitis, Night sweats, No adverse event, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Nail disorder, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ERENUMAB-AOOE, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, ALENDRONATE SODIUM, GOLD, ADALIMUMAB-ADAZ, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, MAGNESIUM CHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NICOTINAMIDE, MEPOLIZUMAB, ABATACEPT, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RANITIDINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DICLOFENAC EPOLAMINE, DICLOFENAC EPOLAMINE, CYANOCOBALAMIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORAZEPAM, PREDNISOLONE ACETATE, |
||||
| 512 | 26479010 |
CA |
63 | 1 |
Type 2 diabetes mellitus, Nasopharyngitis, Arthralgia, Joint stiffness, Bone demineralisation, |
||||
GOLIMUMAB, |
||||
| 513 | 26479434 |
62 | ||
Oropharyngeal pain, Nasopharyngitis, Candida infection, |
||||
BIMEKIZUMAB, |
||||
| 514 | 26479585 |
US |
2 | |
Pneumonia, Nasopharyngitis, Tonsillitis, Lymphadenopathy, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 515 | 26479626 |
US |
79 | 2 |
Surgery, Therapeutic response shortened, Sciatica, Blood pressure increased, Anxiety, Nasopharyngitis, |
||||
EPTINEZUMAB-JJMR, |
||||
| 516 | 26479649 |
US |
69 | 1 |
Nasopharyngitis, |
||||
LENALIDOMIDE, |
||||
| 517 | 26471282 |
US |
84 | 1 |
Nasopharyngitis, Product use in unapproved indication, |
||||
ISAVUCONAZONIUM SULFATE, |
||||
| 518 | 26471622 |
US |
1 | |
Back pain, Nasopharyngitis, Myalgia, Neck pain, |
||||
EVOLOCUMAB, |
||||
| 519 | 26471629 |
US |
45 | 2 |
Seizure, Nasopharyngitis, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 520 | 26471774 |
US |
1 | |
Sinus congestion, Nasopharyngitis, |
||||
PIMAVANSERIN TARTRATE, SAFINAMIDE MESYLATE, MAGNESIUM, ASCORBIC ACID, ISTRADEFYLLINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FAMOTIDINE, RIVASTIGMINE, MAGNESIUM, QUETIAPINE, AMANTADINE, CARBIDOPA AND LEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FAMOTIDINE, SAFINAMIDE MESYLATE, OPICAPONE, CARBIDOPA AND LEVODOPA, |
||||
| 521 | 26471829 |
US |
52 | 2 |
Nasopharyngitis, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 522 | 26471907 |
US |
42 | 1 |
Colitis ulcerative, Diarrhoea, Nasopharyngitis, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, FISH OIL, CETIRIZINE HYDROCHLORIDE, |
||||
| 523 | 26471973 |
BR |
2 | |
Pneumonia bacterial, Weight decreased, Asthenia, Dyspnoea, Fatigue, Obstructive airways disorder, Pneumonia, Anaemia, Diarrhoea, Fatigue, Pneumonia, Insomnia, Nervousness, Renal injury, Back pain, Hypothyroidism, Hyperthyroidism, Somnolence, Nausea, Blood pressure increased, Neuralgia, Abdominal discomfort, Nodule, Renal disorder, Retching, Pain in extremity, Pain, Decreased immune responsiveness, Vomiting, Malaise, Myalgia, Dizziness, Palpitations, Headache, Vertigo, Vitamin D decreased, Abdominal pain, Constipation, Memory impairment, Feeding disorder, Platelet count decreased, Bone pain, Anaemia, Decreased immune responsiveness, Weight increased, Gait disturbance, Musculoskeletal stiffness, Muscle spasms, Head discomfort, Dyskinesia, Hypoacusis, Muscular weakness, Tooth disorder, Root canal infection, Pulpitis dental, Insomnia, Nasopharyngitis, Decreased immune responsiveness, Influenza, Cough, Allergic cough, Peripheral swelling, Pain, Product prescribing error, Decreased immune responsiveness, Sensitivity to weather change, Influenza, Pain, Musculoskeletal chest pain, Decreased immune responsiveness, Hypotension, Musculoskeletal chest pain, Feeding disorder, Drug intolerance, Contusion, Parosmia, Crying, Vomiting, Memory impairment, Dyspnoea, Influenza, Pyrexia, Malaise, Asthenia, Eating disorder, Ecchymosis, Pain in extremity, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, MORPHINE, MORPHINE, ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, EXEMESTANE, AMOXICILLIN, MORPHINE, |
||||
| 524 | 26472051 |
CA |
71 | 2 |
Haematochezia, Alopecia, Frequent bowel movements, Abdominal distension, Nasopharyngitis, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, PREDNISONE, |
||||
| 525 | 26472066 |
US |
2 | |
Nasopharyngitis, |
||||
EVOLOCUMAB, |
||||
| 526 | 26472809 |
US |
||
Nasopharyngitis, Product dose omission issue, Pyrexia, |
||||
LENALIDOMIDE, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, VITAMIN E, CALCIUM CARBONATE, ANTACID, |
||||
| 527 | 26472974 |
US |
48 | 2 |
Overdose, Nasopharyngitis, Cough, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 528 | 26473032 |
CA |
45 | 2 |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Pyrexia, Rash, Rheumatoid arthritis, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Weight increased, Wound, |
||||
RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
| 529 | 26473053 |
GB |
||
Arthritis, Nasopharyngitis, |
||||
METHOTREXATE SODIUM, |
||||
| 530 | 26473264 |
CA |
50 | 1 |
Respiratory syncytial virus infection, Blood pressure fluctuation, Oxygen saturation decreased, Blood pressure increased, Malaise, Inappropriate schedule of product administration, Cough, Dyspnoea, Nasopharyngitis, Weight decreased, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, ALBUTEROL, AVACOPAN, LISINOPRIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PREDNISONE, ERGOCALCIFEROL, CALCIUM, |
||||
| 531 | 26473466 |
US |
42 | 2 |
Hip arthroplasty, Nasopharyngitis, Pain, |
||||
UPADACITINIB, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FOLIC ACID, |
||||
| 532 | 26473564 |
41 | ||
Gastrointestinal disorder, Weight decreased, Pharyngitis streptococcal, Rash, Vertigo, Nasopharyngitis, Product availability issue, Product dose omission issue, Therapy interrupted, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 533 | 26473717 |
CA |
39 | |
Pneumonia, Nasal congestion, Dyspnoea, Bronchitis, Nasopharyngitis, Cough, |
||||
OMALIZUMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 534 | 26473863 |
GB |
72 | 2 |
Lymphadenopathy, Brain fog, Myalgia, Rash vesicular, Dyspnoea, Fatigue, Nasopharyngitis, Rhinorrhoea, |
||||
DENOSUMAB, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), CALCIUM CARBONATE, ANTACID, |
||||
| 535 | 26474284 |
US |
77 | 2 |
Arthralgia, Nasopharyngitis, Joint swelling, |
||||
ABATACEPT, |
||||
| 536 | 26474301 |
PE |
63 | 2 |
Hypoacusis, Decreased immune responsiveness, Discouragement, Dysuria, Pain, Urticaria, Gait disturbance, Erythema, Diarrhoea, Malaise, Arthralgia, Headache, Epistaxis, Cough, Bone pain, Feeling abnormal, Influenza, Nasopharyngitis, |
||||
FULVESTRANT, RIBOCICLIB, |
||||
| 537 | 26474311 |
US |
52 | 2 |
Pharyngeal swelling, Nausea, Nervousness, Nasopharyngitis, |
||||
REMIBRUTINIB, |
||||
| 538 | 26474438 |
55 | ||
Erysipelas, Nasopharyngitis, Urinary tract infection, |
||||
BIMEKIZUMAB, |
||||
| 539 | 26474443 |
US |
1 | |
Nasopharyngitis, Nasal congestion, Cough, Secretion discharge, Pruritus, |
||||
SAPROPTERIN DIHYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 540 | 26475426 |
US |
1 | |
Pyrexia, Nasopharyngitis, Chills, Pruritus, Formication, |
||||
OSIMERTINIB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, FOLIC ACID, CALCIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MORPHINE, PROMETHAZINE HYDROCHLORIDE, OLANZAPINE, ERGOCALCIFEROL, |
||||
| 541 | 26470773 |
US |
49 | 2 |
Brain fog, Nasopharyngitis, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 542 | 26470873 |
US |
1 | |
Psoriatic arthropathy, Nasopharyngitis, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 543 | 26471006 |
|||
Nasopharyngitis, |
||||
DOXECITINE AND DOXRIBTIMINE, |
||||
| 544 | 26470023 |
|||
Symptom recurrence, Nasopharyngitis, Incorrect dose administered, Accidental exposure to product, Off label use, Device failure, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, |
||||
| 545 | 26470161 |
|||
Nasopharyngitis, Abdominal pain, |
||||
OLEZARSEN SODIUM, |
||||
| 546 | 26470245 |
US |
2 | |
Nasopharyngitis, |
||||
TREPROSTINIL, TREPROSTINIL, MELATONIN, SPIRONOLACTONE, OXYGEN, 0XYGEN, RIVAROXABAN, AMBRISENTAN, |
||||
| 547 | 26470432 |
JP |
10 | 1 |
Mobility decreased, Hyperglycaemic hyperosmolar nonketotic syndrome, Diabetic ketoacidosis, Delirium, Cognitive disorder, Nasopharyngitis, Decreased appetite, |
||||
EMPAGLIFLOZIN, |
||||
| 548 | 26470476 |
25 | ||
Nasopharyngitis, Arthralgia, Pyrexia, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 549 | 26470541 |
US |
2 | |
Nasopharyngitis, |
||||
TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SOTATERCEPT-CSRK, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OXYGEN, 0XYGEN, |
||||
| 550 | 26465308 |
US |
64 | 2 |
Chemotherapy, Diarrhoea, Abdominal pain upper, Fatigue, Constipation, Respiratory tract congestion, Nasopharyngitis, Pain, |
||||
PANCRELIPASE, |
||||
| 551 | 26465412 |
58 | ||
Nasopharyngitis, |
||||
BIMEKIZUMAB, |
||||
| 552 | 26465657 |
CA |
65 | 2 |
Adjustment disorder, Vomiting, Sneezing, Skin haemorrhage, Skin exfoliation, Sinusitis, Gangrene, Fatigue, Fall, Eating disorder, Dysphagia, Dysarthria, Cystitis, Cough, Coordination abnormal, Confusional state, Chest discomfort, Cerebrovascular accident, Cataract, Carotid artery thrombosis, Blood pressure increased, Arthritis, Arterial occlusive disease, Aphasia, Anxiety, Angina pectoris, Affect lability, Gastrointestinal disorder, Headache, Hemiplegia, Sinus disorder, Sinus congestion, Sensory loss, Rhinorrhoea, Rheumatoid arthritis, Respiratory tract congestion, Pyrexia, Psoriasis, Pneumonia, Personality disorder, Palpitations, Pain, Neurologic neglect syndrome, Nausea, Nasopharyngitis, Muscular weakness, Muscle spasticity, Motor dysfunction, Malaise, Influenza like illness, Influenza, Hemiparesis, Asthenia, Product use issue, |
||||
DIMENHYDRINATE, DIMENHYDRINATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LISINOPRIL, ATORVASTATIN CALCIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SITAGLIPTIN, IRBESARTAN, IRBESARTAN, METHOTREXATE, METHOTREXATE SODIUM, ZOLPIDEM TARTRATE, LEVOTHYROXINE SODIUM, IRBESARTAN, IRBESARTAN, IRBESARTAN, RITUXIMAB, RITUXIMAB, PROCHLORPERAZINE, PREDNISONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, MORPHINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, CANDESARTAN, CALCIUM CARBONATE, ANTACID, BISOPROLOL FUMARATE, CANDESARTAN CILEXETIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ERGOCALCIFEROL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, PREGABALIN, INSULIN DETEMIR, INSULIN GLARGINE, HYDROCHLOROTHIAZIDE, INSULIN LISPRO, ZOLPIDEM TARTRATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TELMISARTAN, LEVOTHYROXINE SODIUM, USTEKINUMAB, ROSUVASTATIN, PANTOPRAZOLE, EZETIMIBE, COAL TAR, IRBESARTAN, AMLODIPINE BESYLATE, ACITRETIN, DULOXETINE HYDROCHLORIDE, CYANOCOBALAMIN, METHYLPREDNISOLONE ACETATE, CANDESARTAN CILEXETIL, METHOTREXATE SODIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, METHYLPREDNISOLONE, MORPHINE SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, LISINOPRIL, NAPROXEN, NAPROXEN SODIUM, VITAMIN C, ZOLPIDEM TARTRATE, ROSUVASTATIN CALCIUM, CANDESARTAN CILEXETIL, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ESOMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, PREDNISOLONE SODIUM PHOSPHATE, BISOPROLOL FUMARATE, METHYLPREDNISOLONE ACETATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, PREDNISONE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, BISOPROLOL FUMARATE, IRBESARTAN, IRBESARTAN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 553 | 26465884 |
CA |
71 | 2 |
Dental implant removal, Nasopharyngitis, Productive cough, |
||||
RISANKIZUMAB-RZAA, AMOXICILLIN, |
||||
| 554 | 26465997 |
70 | ||
Nasopharyngitis, |
||||
BIMEKIZUMAB, |
||||
| 555 | 26466029 |
US |
73 | 2 |
Full blood count decreased, Cystitis, Urinary tract infection, Diarrhoea, Escherichia infection, Nasopharyngitis, Rhinorrhoea, Seasonal allergy, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, VITAMIN C, HYDROXYCHLOROQUINE SULFATE, BOSENTAN, CITALOPRAM, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, FUROSEMIDE, GABAPENTIN, ERGOCALCIFEROL, PROCHLORPERAZINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, BENZONATATE, LORATADINE, LORATADINE TABLET, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, EZETIMIBE, OXYGEN, 0XYGEN, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, FOLIC ACID, SILDENAFIL CITRATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, IRBESARTAN, AMLODIPINE BESYLATE, OXYCODONE HYDROCHLORIDE, CLONAZEPAM, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMITRIPTYLINE HYDROCHLORIDE, NIACIN, |
||||
| 556 | 26466157 |
US |
2 | |
Product dose omission issue, Product delivery mechanism issue, Device use issue, Nasopharyngitis, Dyspnoea, Memory impairment, Hypogeusia, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 557 | 26466207 |
US |
70 | 2 |
Nasopharyngitis, Skin disorder, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 558 | 26466638 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Breast cancer stage III, Bursitis, Coeliac disease, Condition aggravated, Confusional state, Contusion, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Hypotension, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Wheezing, Wound, Wound infection, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
| 559 | 26466753 |
CA |
45 | |
Lower respiratory tract infection, Nasopharyngitis, Dizziness, Injection site swelling, Injection site erythema, Injection site pruritus, Product dose omission issue, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 560 | 26466754 |
US |
66 | 1 |
Mycobacterium avium complex infection, Insurance issue, Inappropriate schedule of product administration, Product dose omission issue, Product use issue, Nasopharyngitis, Somnolence, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, EPINEPHRINE, ADRENALINUM, CARVEDILOL, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, ALLOPURINOL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ISOSORBIDE MONONITRATE, NITROGLYCERIN, OXYGEN, 0XYGEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMIODARONE HYDROCHLORIDE, LIDOCAINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, REVEFENACIN, CETIRIZINE HYDROCHLORIDE, SACUBITRIL AND VALSARTAN, GUAIFENESIN, VITAMIN C, FUROSEMIDE, PREDNISONE, |
||||
| 561 | 26466795 |
US |
74 | 2 |
Dysphonia, Nasopharyngitis, |
||||
INSULIN GLARGINE-AGLR, |
||||
| 562 | 26466863 |
|||
Nasopharyngitis, Sinusitis, Liver function test increased, |
||||
OLEZARSEN SODIUM, |
||||
| 563 | 26467058 |
US |
1 | |
Nasopharyngitis, Swollen tongue, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 564 | 26467275 |
65 | ||
Nasopharyngitis, |
||||
BIMEKIZUMAB, |
||||
| 565 | 26467664 |
US |
1 | |
Immunodeficiency, Nasopharyngitis, |
||||
OCRELIZUMAB, |
||||
| 566 | 26467693 |
US |
51 | 2 |
Gastrointestinal disorder, Gastrointestinal disorder, Gastrointestinal disorder, Gastrointestinal disorder, Nasopharyngitis, Abdominal pain upper, Abdominal discomfort, |
||||
GARADACIMAB, |
||||
| 567 | 26467807 |
US |
63 | 1 |
Nasopharyngitis, COVID-19, Eye infection, Respiratory disorder, |
||||
ABATACEPT, |
||||
| 568 | 26467820 |
US |
77 | 2 |
Choking, Knee arthroplasty, Macular degeneration, Superficial injury of eye, Fatigue, Sarcoidosis, Musculoskeletal stiffness, Stress, Memory impairment, Dysphagia, Cough, Astigmatism, Paranoia, Dizziness, Walking aid user, Anxiety, Language disorder, Eyelid function disorder, Psoriasis, Photosensitivity reaction, Contusion, Asthenia, Asthenopia, Sinusitis, Influenza, Headache, Pain, Nasopharyngitis, Amnesia, Pharyngitis, Corneal abrasion, Therapeutic response decreased, |
||||
NIPOCALIMAB, |
||||
| 569 | 26468237 |
CA |
42 | 2 |
Pneumonia, Nasopharyngitis, Influenza, |
||||
EPTINEZUMAB-JJMR, ATORVASTATIN CALCIUM, |
||||
| 570 | 26468357 |
CA |
43 | 2 |
Alopecia, Arthropathy, Asthenia, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Hand deformity, Helicobacter infection, Hypertension, Hypoaesthesia, Inflammation, Lip dry, Liver injury, Lower respiratory tract infection, Maternal exposure during pregnancy, Mobility decreased, Muscle injury, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Obesity, Osteoarthritis, Pemphigus, Pericarditis, Psoriatic arthropathy, Stomatitis, Swelling, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Wheezing, Wound infection, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
| 571 | 26468436 |
|||
Nasopharyngitis, Product dose omission issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 572 | 26468503 |
45 | ||
Nasopharyngitis, Illness, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 573 | 26468617 |
GB |
1 | |
Pulmonary function test decreased, Nasopharyngitis, Product dose omission issue, |
||||
IVACAFTOR, DORNASE ALFA, |
||||
| 574 | 26468623 |
US |
||
Haemoptysis, Nasopharyngitis, |
||||
VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR, |
||||
| 575 | 26469300 |
|||
Nasopharyngitis, |
||||
BIMEKIZUMAB, |
||||
| 576 | 26469441 |
US |
||
Nasopharyngitis, |
||||
PEGCETACOPLAN, |
||||
| 577 | 26469554 |
34 | ||
Maternal exposure before pregnancy, Maternal exposure during pregnancy, Caesarean section, Respiratory tract infection, Pyrexia, Nasopharyngitis, Influenza, Urinary tract infection, |
||||
CERTOLIZUMAB PEGOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE, CAFFEINE, CAFFEINE, CEFDINIR, LORATADINE, LORATADINE TABLET, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, LABETALOL, LABETALOL, LABETALOL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PROGESTERONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 578 | 26460608 |
US |
2 | |
Nasopharyngitis, Product use issue, Product dose omission issue, |
||||
SITAGLIPTIN PHOSPHATE, |
||||
| 579 | 26461054 |
US |
63 | 2 |
Arthralgia, Nasopharyngitis, Rhinorrhoea, Sneezing, |
||||
SECUKINUMAB, |
||||
| 580 | 26461214 |
CA |
32 | 2 |
Bacterial infection, Forced expiratory volume decreased, Influenza, Musculoskeletal chest pain, Fungal infection, Obstructive airways disorder, Pneumonia, Tachycardia, Urticaria, Vomiting, Blood pressure increased, Decreased activity, Nasal congestion, Pain, Productive cough, Rales, Upper-airway cough syndrome, Vertigo, Dizziness, Psoriasis, Rhinitis, Terminal insomnia, Therapeutic product effect decreased, Therapeutic response decreased, Cough, Diarrhoea, Emphysema, Malaise, Nasal discharge discolouration, Urinary tract infection, Wheezing, Abdominal pain, Asthma, Dyspnoea exertional, Eczema, Feeding disorder, Full blood count abnormal, Oropharyngeal pain, Sleep disorder, Sleep disorder due to a general medical condition, Ear infection, Middle insomnia, Migraine, Nasopharyngitis, Restrictive pulmonary disease, Sinusitis, Stress, Anxiety, Drug ineffective, Dyspnoea, Eosinophil count abnormal, Heart rate increased, Infection, Product administration error, Tooth abscess, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, MONTELUKAST SODIUM, MONTELUKAST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMALIZUMAB, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TERBUTALINE SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, CICLESONIDE, SEMAGLUTIDE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 581 | 26461306 |
CA |
24 | 2 |
Migraine, Neck pain, Ankylosing spondylitis, Nasopharyngitis, Visual impairment, Arthritis, Sacral pain, Weight increased, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, TIRZEPATIDE, ERGOCALCIFEROL, VITAMIN C, ALMOTRIPTAN, |
||||
| 582 | 26461583 |
US |
76 | 2 |
Nasopharyngitis, |
||||
TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, CLONIDINE HYDROCHLORIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, EZETIMIBE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PRAVASTATIN SODIUM, ICOSAPENT ETHYL, ICOSAPENT ETHYL CAPSULES, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ERGOCALCIFEROL, ALBUTEROL SULFATE, GABAPENTIN, MACITENTAN, OXYGEN, 0XYGEN, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 583 | 26461657 |
US |
46 | 2 |
Pneumonia, Nasopharyngitis, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 584 | 26461747 |
CA |
81 | 2 |
Peripheral swelling, Asthenia, Nasopharyngitis, Product dose omission issue, |
||||
GOLIMUMAB, |
||||
| 585 | 26461992 |
GB |
59 | 2 |
Surgery, Psoriasis, Nasopharyngitis, Product dose omission issue, |
||||
GUSELKUMAB, |
||||
| 586 | 26462094 |
22 | ||
Nasopharyngitis, Illness, |
||||
BIMEKIZUMAB, |
||||
| 587 | 26462184 |
US |
66 | 2 |
Pneumonia, Device malfunction, Incorrect drug administration rate, Fatigue, Nasopharyngitis, Device use issue, Asthenia, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 588 | 26462360 |
US |
28 | 1 |
Device leakage, Product dose omission issue, Illness, Nasopharyngitis, Adverse drug reaction, Abdominal discomfort, Infection, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
| 589 | 26462699 |
US |
76 | 1 |
Cellulitis, Nasopharyngitis, COVID-19, Muscle strain, Brain fog, Loss of personal independence in daily activities, Asthenia, |
||||
IBRUTINIB, |
||||
| 590 | 26462724 |
1 | ||
Therapy interrupted, Product distribution issue, Cough, Nasopharyngitis, Drug ineffective, Dehydration, Blood cholesterol increased, |
||||
PIRTOBRUTINIB, |
||||
| 591 | 26462729 |
GB |
57 | 2 |
Nasopharyngitis, Feeling abnormal, Headache, Musculoskeletal pain, Pain in extremity, Mobility decreased, Fatigue, Memory impairment, Heart rate decreased, |
||||
SIPONIMOD, SIPONIMOD, |
||||
| 592 | 26462764 |
CA |
53 | |
Back pain, Contusion, Cough, Diarrhoea, Dry eye, Ear infection, Fatigue, Heart rate increased, Hypoacusis, Lower respiratory tract infection, Migraine, Nasal congestion, Oral herpes, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Rhinorrhoea, Sunburn, Urticaria, Weight decreased, Weight increased, Drug hypersensitivity, Influenza, Injection site bruising, Illness, Nasopharyngitis, Inappropriate schedule of product administration, Incorrect dose administered, Intentional product use issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, BACLOFEN, CARBAMAZEPINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLARITHROMYCIN, CLONAZEPAM, VANCOMYCIN HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, PREDNISONE, |
||||
| 593 | 26462790 |
US |
||
Lower respiratory tract infection, Nasopharyngitis, |
||||
| 594 | 26462913 |
|||
Bronchitis, Sinusitis, Nasopharyngitis, |
||||
CERTOLIZUMAB PEGOL, LEVOTHYROXINE SODIUM, LISDEXAMFETAMINE DIMESYLATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 595 | 26463037 |
US |
||
Nasopharyngitis, Rash, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 596 | 26463187 |
CA |
53 | 2 |
Lower respiratory tract infection, Pharyngitis, Stress, Weight decreased, Condition aggravated, Nasopharyngitis, |
||||
MESALAMINE, PANTOPRAZOLE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, GABAPENTIN, |
||||
| 597 | 26463225 |
CA |
66 | 2 |
Abdominal discomfort, Abdominal mass, Abdominal pain lower, Blood pressure increased, Headache, Heart rate increased, Hip surgery, Muscle spasms, Nasopharyngitis, Nausea, Throat irritation, Product prescribing error, Off label use, Inappropriate schedule of product administration, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CALCIUM, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, MAGNESIUM, METHYLPREDNISOLONE, PANTOPRAZOLE, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 598 | 26463253 |
US |
2 | |
Nasopharyngitis, |
||||
| 599 | 26463278 |
US |
57 | 2 |
Illness, Nasopharyngitis, Product dose omission issue, |
||||
| 600 | 26463385 |
38 | ||
Nasopharyngitis, Urinary tract infection, |
||||
BIMEKIZUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28